@article{kim_kim_kim_kim_kim_2022, 
  title={Transient Mutism Related to Capecitabine-Induced Acute Toxic Leukoencephalopathy}, 
  volume={40}, 
  DOI={10.17340/jkna.2022.2.13}, 
  abstractNote={<jats:p>Capecitabine, a precursor of 5-fluorouracil (5-FU), is a well-tolerated and safe chemotherapy that has been used to treat breast, pancreatic, and colorectal cancers. Albeit rare, both 5-FU and capecitbine have been reported to be associated with acute central nervous system toxicity, including cerebellar dysfunction, posterior reversible encephalopathy syndrome, and transient leukoencephalopathies. Here we present a case of 32-year-old female, demonstrating transient mutism related to capecitabine induced acute toxic leukoencephalopathy.</jats:p>}, 
  publisher={Korean Neurological Association}, 
  author={Kim, Hyung Ho and Kim, Hyunji and Kim, Sumin and Kim, Soo-Hyun and Kim, Geon Ha}, 
  year={2022}, 
  month={May}
  }